The arrival of the the medication vial represents a significant breakthrough in the field to metabolic management . This innovative drug combines dual mechanisms – activation of the GLP-1 site and blocking of the DPP-4 enzyme – providing a unique strategy for managing excess weight . Early clinical data suggest encouraging results in promoting